ZICONOTIDE

Course overview

ZICONOTIDE IS A NEWER, INTRATHECAL ANALGESIC MEDICATION USED FOR THE TREATMENT OF CHRONIC PAIN. ITS FDA INDICATION IS FOR THE TREATMENT OF CHRONIC SEVERE PAIN IN PATIENTS THAT ARE INTOLERANT OR REFRACTORY TO SYSTEMIC ANALGESICS OR INTRATHECAL MORPHINE. ZICONOTIDE CAN ONLY BE ADMINISTERED INTRATHECALLY AS IT DOES NOT CROSS THE BLOOD-BRAIN BARRIER WELL. IT SHOWS EFFICACY IN THE TREATMENT OF INTRACTABLE, SEVERE, CHRONIC PAIN SECONDARY TO CANCER AND ALSO IN NON-MALIGNANT PAIN. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, METHODS OF ADMINISTRATION, IMPORTANT ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICITY, AND MONITORING, OF ZICONOTIDE, SO PROVIDERS CAN DIRECT PATIENT THERAPY WHERE IT IS INDICATED FOR PAIN RELIEF AS PART OF THE INTERPROFESSIONAL TEAM.